Vasodilator Therapies in the Treatment of Acute Heart Failure
PURPOSE OF REVIEW: Vasodilators are commonly recommended to treat acute heart failure (AHF), yet they are infrequently used. This review aims to evaluate the clinical utility of traditional, historical, and novel vasodilators in the treatment of AHF.
RECENT FINDINGS: No traditional vasodilator (i.e., nitroglycerin) therapy definitely improves short- or long-term outcomes. Despite repeated efforts to develop new pharmacologic treatments, no novel therapy outperforms traditional management. At the present time, we continue to recommend traditional vasodilators, such as nitroglycerin. The use of select vasodilators in the treatment of AHF improves hemodynamics and provides short-term relief; however, data regarding long-term benefits is lacking.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
|---|---|
| Enthalten in: |
Current heart failure reports - 16(2019), 1 vom: 14. Feb., Seite 32-37 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Holt, Daniel B [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Acute heart failure |
|---|
| Anmerkungen: |
Date Completed 24.02.2020 Date Revised 09.03.2020 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1007/s11897-019-0421-4 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM293877572 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM293877572 | ||
| 003 | DE-627 | ||
| 005 | 20231225080253.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s11897-019-0421-4 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0979.xml |
| 035 | |a (DE-627)NLM293877572 | ||
| 035 | |a (NLM)30762175 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Holt, Daniel B |c Jr |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Vasodilator Therapies in the Treatment of Acute Heart Failure |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 24.02.2020 | ||
| 500 | |a Date Revised 09.03.2020 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a PURPOSE OF REVIEW: Vasodilators are commonly recommended to treat acute heart failure (AHF), yet they are infrequently used. This review aims to evaluate the clinical utility of traditional, historical, and novel vasodilators in the treatment of AHF | ||
| 520 | |a RECENT FINDINGS: No traditional vasodilator (i.e., nitroglycerin) therapy definitely improves short- or long-term outcomes. Despite repeated efforts to develop new pharmacologic treatments, no novel therapy outperforms traditional management. At the present time, we continue to recommend traditional vasodilators, such as nitroglycerin. The use of select vasodilators in the treatment of AHF improves hemodynamics and provides short-term relief; however, data regarding long-term benefits is lacking | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Acute heart failure | |
| 650 | 4 | |a Vasodilator(s) | |
| 650 | 7 | |a Vasodilator Agents |2 NLM | |
| 700 | 1 | |a Pang, Peter S |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Current heart failure reports |d 2004 |g 16(2019), 1 vom: 14. Feb., Seite 32-37 |w (DE-627)NLM156716283 |x 1546-9549 |7 nnns |
| 773 | 1 | 8 | |g volume:16 |g year:2019 |g number:1 |g day:14 |g month:02 |g pages:32-37 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s11897-019-0421-4 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 16 |j 2019 |e 1 |b 14 |c 02 |h 32-37 | ||